signature care acid reducer complete

Generic: famotidine, calcium carbonate, magnesium hydroxide

Labeler: safeway
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name signature care acid reducer complete
Generic Name famotidine, calcium carbonate, magnesium hydroxide
Labeler safeway
Dosage Form TABLET, CHEWABLE
Routes
ORAL
Active Ingredients

calcium carbonate 800 mg/1, famotidine 10 mg/1, magnesium hydroxide 165 mg/1

Manufacturer
Safeway

Identifiers & Regulatory

Product NDC 21130-546
Product ID 21130-546_b75fd606-49ad-47c4-8f4c-b4dd4eb9ce9d
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA077355
Listing Expiration 2026-12-31
Marketing Start 2021-11-01

Pharmacologic Class

Established (EPC)
histamine-2 receptor antagonist [epc]
Mechanism of Action
histamine h2 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 21130546
Hyphenated Format 21130-546

Supplemental Identifiers

RxCUI
283641
UNII
H0G9379FGK 5QZO15J2Z8 NBZ3QY004S
NUI
N0000000151 N0000175784

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name signature care acid reducer complete (source: ndc)
Generic Name famotidine, calcium carbonate, magnesium hydroxide (source: ndc)
Application Number ANDA077355 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 800 mg/1
  • 10 mg/1
  • 165 mg/1
source: ndc
Packaging
  • 25 TABLET, CHEWABLE in 1 BOTTLE (21130-546-63)
  • 50 TABLET, CHEWABLE in 1 BOTTLE (21130-546-71)
source: ndc

Packages (2)

21130-546-63 25 TABLET, CHEWABLE in 1 BOTTLE (21130-546-63) 21130-546-71 50 TABLET, CHEWABLE in 1 BOTTLE (21130-546-71)

Ingredients (3)

calcium carbonate (800 mg/1) famotidine (10 mg/1) magnesium hydroxide (165 mg/1)

Linked Drug Pages (1)

signature care acid reducer complete ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "b75fd606-49ad-47c4-8f4c-b4dd4eb9ce9d", "openfda": {"nui": ["N0000000151", "N0000175784"], "unii": ["H0G9379FGK", "5QZO15J2Z8", "NBZ3QY004S"], "rxcui": ["283641"], "spl_set_id": ["885f43ab-5c14-417b-aab7-e887dfc48f2e"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Safeway"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 TABLET, CHEWABLE in 1 BOTTLE (21130-546-63)", "package_ndc": "21130-546-63", "marketing_start_date": "20211101"}, {"sample": false, "description": "50 TABLET, CHEWABLE in 1 BOTTLE (21130-546-71)", "package_ndc": "21130-546-71", "marketing_start_date": "20211101"}], "brand_name": "signature care acid reducer complete", "product_id": "21130-546_b75fd606-49ad-47c4-8f4c-b4dd4eb9ce9d", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Calculi Dissolution Agent [EPC]", "Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "21130-546", "generic_name": "Famotidine, Calcium Carbonate, Magnesium Hydroxide", "labeler_name": "Safeway", "product_type": "HUMAN OTC DRUG", "brand_name_base": "signature care acid reducer complete", "active_ingredients": [{"name": "CALCIUM CARBONATE", "strength": "800 mg/1"}, {"name": "FAMOTIDINE", "strength": "10 mg/1"}, {"name": "MAGNESIUM HYDROXIDE", "strength": "165 mg/1"}], "application_number": "ANDA077355", "marketing_category": "ANDA", "marketing_start_date": "20211101", "listing_expiration_date": "20261231"}